AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Abattis Bioceuticals Corp.

$0 +$0.00 (+0.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
14.33K
AVG Volume
22.32K
Trailing/Forward PE
-0.01/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD)
0100K200K300K17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Revenue (CAD) by quarter
PeriodRevenue (CAD)
19 Q4226.27K
19 Q3127.79K
19 Q22.17K
19 Q1643
18 Q42.47K
18 Q3237
18 Q25.67K
18 Q10
17 Q40
17 Q30
Net Income (CAD)
-60M-40M-20M017 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Net Income (CAD) by quarter
PeriodNet Income (CAD)
19 Q4-907.06K
19 Q3-735.66K
19 Q2-142.54K
19 Q1-1.26M
18 Q4-54.2M
18 Q3-6.94M
18 Q2-11.66M
18 Q1-5.22M
17 Q4-3.76M
17 Q3-1.99M
Operating Income (CAD)
-15M-10M-5M05M10M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
19 Q4-470.1K
19 Q3-790.43K
19 Q2-1.05M
19 Q1-1.6M
18 Q47.43M
18 Q3-6.95M
18 Q2-11.65M
18 Q1-6.21M
17 Q4-2.28M
17 Q3-2.08M
EBITDA (CAD)
-15M-10M-5M05M10M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
19 Q4-423.69K
19 Q3-769.18K
19 Q2-121.45K
19 Q1-1.58M
18 Q45.53M
18 Q3-5.02M
18 Q2-11.65M
18 Q1-6.21M
17 Q4-2.24M
17 Q3-2.06M
Cash Flows (CAD)
-5M05M10M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
19 Q4-1.1M
19 Q37.5M
19 Q2-607.48K
19 Q1-1.44M
18 Q4-1.5M
18 Q3-3.58M
18 Q2-440.99K
18 Q1-3M
17 Q4-384.86K
17 Q3-571.26K
EPS (CAD)
-0.15-0.1-0.05-017 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF EPS (CAD) by quarter
PeriodEPS (CAD)
19 Q4-0
19 Q3-0
19 Q2-0
19 Q1-0
18 Q4-0.13
18 Q3-0.02
18 Q2-0.04
18 Q1-0.03
17 Q4-0.02
17 Q3-0.01
Expenses (CAD)
-10M-5M05M10M15MR&DSG&ACapex17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Expenses (CAD) by quarter
PeriodExpenses (CAD)
19 Q45.67M
19 Q3847.11K
19 Q21.06M
19 Q11.63M
18 Q4-6.34M
18 Q35.03M
18 Q211M
18 Q16.34M
17 Q42.15M
17 Q32.48M
Cash & Debt (CAD)
05M10M15M20MCashLong Term DebtShort Term Debt17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
19 Q42.4M
19 Q33.39M
19 Q24.68M
19 Q15.76M
18 Q49.1M
18 Q36.36M
18 Q219.45M
18 Q18.85M
17 Q4525.57K
17 Q3866.75K
Debt ratios
-202417 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Debt ratios by quarter
PeriodDebt ratios
19 Q40.29
19 Q3-0.62
19 Q23.92
19 Q10.45
18 Q40.52
18 Q30.22
18 Q20.84
18 Q10.74
17 Q40.08
17 Q30.17
Margins
0%50%100%150%15 Q416 Q116 Q418 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Margins by quarter
PeriodMargins
19 Q471.66%
19 Q359.77%
19 Q2100%
19 Q1100%
18 Q4100%
18 Q3100%
18 Q266.57%
16 Q4100%
16 Q1100%
15 Q4135.6%
Return on Capital
-600%-400%-200%0%17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Return on Capital by quarter
PeriodReturn on Capital
19 Q4-8.5%
19 Q3-6.34%
19 Q2-1.11%
19 Q1-9.84%
18 Q4-488.42%
18 Q3-10.1%
18 Q2-17%
18 Q1-48.38%
17 Q4-487.93%
17 Q3-104.34%
Shares Outstanding
0200M400M600M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Shares Outstanding by quarter
PeriodShares Outstanding
19 Q4477.88M
19 Q3477.8M
19 Q2477.65M
19 Q1448.95M
18 Q4420.96M
18 Q3387.44M
18 Q2298.27M
18 Q1185.14M
17 Q4187.5M
17 Q3153.4M
Book Value Per Share (CAD)
00.10.20.317 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
19 Q40.02
19 Q30.02
19 Q20.03
19 Q10.03
18 Q40.03
18 Q30.18
18 Q20.23
18 Q10.06
17 Q40
17 Q30.01
Total Assets (CAD)
020M40M60M80M17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ATTBF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
19 Q419.26M
19 Q320.41M
19 Q213.13M
19 Q113.15M
18 Q411.4M
18 Q370.08M
18 Q272.53M
18 Q111.29M
17 Q41.21M
17 Q32.62M
Abattis Bioceuticals Corp.
ATTBF
Stockpicker

Video analysis: ATTBF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.